Effect of phonophoresis on serum salicylate levels.

The purpose of this investigation was to determine the effect of ultrasound intensity and mode on serum salicylate levels following phonophoresis. Approximately 12-13 g of a salicylate product (Myoflex) was applied to the right anterior forearm of five males and two females. Randomly ordered ultrasound treatment intensities (0.0 W.cm-2; 1.5 W.cm-2, pulsed 50%; and 1.5 W.cm-2, continuous) were applied through the salicylate-containing product for a 5 min duration. A 7.0 ml blood sample was drawn from the left anterior forearm prior to each treatment and again 2 h after treatment. Analysis of variance indicated that none of the topical salicylate treatments produced an increase in serum salicylate levels. These findings suggest that there is no appreciable absorption of salicylate into the bloodstream following topical application of salicylate with or without the use of ultrasound. Since any penetration of salicylate through the skin would result in an increase in serum salicylate levels, the efficacy of phonophoresis to introduce medication into the subdermal tissue is questionable. These findings suggest that a critical review of phonophoresis in general is indicated.

[1]  J. McElnay,et al.  Use of ultrasound to enhance percutaneous absorption of benzydamine. , 1989, Physical therapy.

[2]  J. Albright,et al.  Distribution and deposition of tritiated cortisol using phonophoresis. , 1988, Physical therapy.

[3]  C. Brewster,et al.  Physical therapy treatment of knee extensor mechanism disorders: comparison of four treatment modalities*. , 1986, The Journal of orthopaedic and sports physical therapy.

[4]  F. Winn,et al.  Comparative Study using Four Modalities in Shinsplint Treatments*. , 1986, The Journal of orthopaedic and sports physical therapy.

[5]  D. J. Blomberg.  Disposition of Toxic Drugs and Chemicals in Man , 1983 .

[6]  T. J. Antich.  Phonophoresis: the principles of the ultrasonic driving force and efficacy in treatment of common orthopaedic diagnoses. , 1982, The Journal of orthopaedic and sports physical therapy.

[7]  William S Quillin.  Ultrasonic Phonophoresis. , 1982, The Physician and sportsmedicine.

[8]  H. Maibach.  Physicians' desk reference for nonprescription drugs, ed. 1.. Medical Economics Co., Oradell, NJ (1980), 721 pages. $12.25. , 2017 .

[9]  J. Griffin,et al.  Physical agents for physical therapists , 1979 .

[10]  J. A. Kleinkort,et al.  Phonophoresis with 1 percent versus 10 percent hydrocortisone. , 1975, Physical therapy.

[11]  J. Griffin,et al.  Effects of ultrasonic frequency on phonophoresis of cortisol into swine tissues. , 1972, American journal of physical medicine.

[12]  J. Griffin,et al.  Low-intensity phonophoresis of cortisol in swine. , 1968, Physical therapy.

[13]  J. Echternach,et al.  Patients treated with ultrasonic driven hydrocortisone and with ultrasound alone. , 1967, Physical therapy.

[14]  J. Griffin,et al.  ULTRASONIC MOVEMENT OF CORTISOL INTO PIG TISSUE. II. MOVEMENT INTO PARAVERTEBRAL NERVE. , 1965, American journal of physical medicine.

[15]  L. Hollister,et al.  Studies of delayed‐action medication , 1965 .

[16]  J. Griffin,et al.  ULTRASONIC MOVEMENT OF CORTISOL INTO PIG TISSUES I. MOVEMENT INTO SKELETAL MUSCLE , 1963, American journal of physical medicine.